Transforming Early Cancer Detection with Liquid Biopsy, Automation, and AI
Swathi Kodaikal, MSc
The liquid biopsy market is expected to increase by approximately 20 percent between 2022 and 2032
A roundup of this year's advances in cancer research, compliance, automation, lab management, and more!
The application is the first of its kind to be recognized by the FDA
A collaborative effort between UT Health San Antonio and UTSA trains clinicians to leverage AI to deliver top-class patient care